« FDA Provides Web Access to Information on Post-Approval Device Studies | Main | FDA Finalizes Report on 2006 Spinach Outbreak The Food and »

FDA Approvals - GSK and Adolor Announce Preliminary Results From Phase 3 Safety


GSK and Adolor Announce Preliminary Results From Phase 3 Safety Study of Alvimopan (ENTEREG/ENTRAREG(R)) (RedNova)
GlaxoSmithKline (LSE and NYSE:GSK) and Adolor Corporation (Nasdaq:ADLR) today announced data from Study 767905/014 and provided an update on the clinical development program for alvimopan (Entereg/Entrareg ).

Zheng to go on trial for graft (China Economic Net)
The former State Food and Drug Administration (FDA) chief Zheng Xiaoyu, who was expelled from the Communist Party of China (CPC) last month, has been accused of taking bribes totaling more than 5 million yuan ($647,000), Xinhua News Agency reported yesterday.

Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2007 Fourth Quarter Earnings (PR Newswire via Yahoo! Finance)
Forest Laboratories, Inc. , an international manufacturer and marketer of pharmaceutical products, will release its Fiscal 2007 Fourth Quarter financial results before the U.S. stock market opens on Tuesday, April 24, 2007.
 

©2006 FDA-News.com. All rights reserved.